18.55
-0.05
(-0.27%)
At close: 1:30:39 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,406,284
3,406,284
3,186,083
3,264,045
2,762,335
Cost of Revenue
2,106,074
2,106,074
1,970,094
2,013,273
1,481,848
Gross Profit
1,300,210
1,300,210
1,215,989
1,250,772
1,280,487
Operating Expense
977,501
977,501
901,565
845,139
991,744
Operating Income
322,709
322,709
314,424
405,633
288,743
Net Non Operating Interest Income Expense
53,438
53,438
44,481
14,207
12,832
Pretax Income
413,017
413,017
348,840
437,960
302,286
Tax Provision
73,667
73,667
61,784
84,744
58,815
Net Income Common Stockholders
339,350
339,350
287,056
353,216
243,471
Diluted NI Available to Com Stockholders
339,350
339,350
287,056
353,216
243,471
Basic EPS
0.43
--
0.36
0.45
0.31
Diluted EPS
0.43
--
0.36
0.45
0.31
Basic Average Shares
789,186.05
--
797,377.78
790,739
790,739
Diluted Average Shares
789,186.05
--
797,377.78
792,681
792,284
Total Expenses
3,083,575
3,083,575
2,871,659
2,858,412
2,473,592
Net Income from Continuing & Discontinued Operation
339,350
339,350
287,056
353,216
243,471
Normalized Income
340,720.49
340,720.49
287,000.87
353,325.68
243,570.87
Interest Income
61,521
61,521
53,628
22,120
19,380
Interest Expense
8,083
8,083
9,147
7,913
6,548
Net Interest Income
53,438
53,438
44,481
14,207
12,832
EBIT
421,100
421,100
357,987
445,873
308,834
EBITDA
909,381
909,381
819,154
885,338
690,366
Reconciled Cost of Revenue
2,106,074
2,106,074
1,970,094
2,013,273
1,481,848
Reconciled Depreciation
488,281
488,281
461,167
439,465
381,532
Net Income from Continuing Operation Net Minority Interest
339,350
339,350
287,056
353,216
243,471
Total Unusual Items Excluding Goodwill
-1,668
-1,668
67
-136
-124
Total Unusual Items
-1,668
-1,668
67
-136
-124
Normalized EBITDA
911,049
911,049
819,087
885,474
690,490
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-297.51
-297.51
11.87
-26.32
-24.13
12/31/2021 - 9/29/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4108.TW PhytoHealth Corporation
13.15
0.00%
1720.TW Standard Chemical & Pharmaceutical Co. Ltd.
58.00
+1.05%
1731.TW Maywufa Company Ltd.
21.85
+0.92%
3705.TW YungShin Global Holding Corporation
66.90
+1.21%
4119.TW SCI Pharmtech, Inc.
69.90
-0.57%
4746.TW Formosa Laboratories, Inc.
58.50
-0.51%
4123.TWO Center Laboratories, Inc.
34.90
-0.43%
4105.TWO TTY Biopharm Company Limited
72.90
+0.41%
4114.TWO Synmosa Biopharma Corporation
31.25
+0.32%
1795.TW Lotus Pharmaceutical Co., Ltd.
213.00
-0.70%